Skip to main content

Fiscal Wizard · Single-issue tearsheet

DBVT / Jun 21, 2026 Run #7429

DBVT

DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Composite verdict

D 34.1 / 100
Bearish setup · Trend Following 15 drivers · gates clear
  • Williams %R
  • Accumulation/Distribution Line
  • MA Rejection
  • Parabolic SAR Flip
  • Trendline Break
  • Coppock Curve
Consider long put target Δ ~0.50 · ~35 DTE Bearish setup, Grade C → ITM put target

Industry rank 143rd of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 19%Evidence: Low · 38 signals81% Bear
Momentum Bearish 13Mean-reversion Neutral 59

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -88%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

33.7 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 100
Margin of Safety 0
Revenue Growth (YoY) 100
Free Cash Flow Yield 0
Gross Margin 75
Return on Assets 21

Technicals Bearish

34.6 / 100

Bearish setup leads (Parabolic SAR Flip, Trendline Break, Coppock Curve). · 43 signals shown.

Strongest
Weakest
Williams %R 92
Parabolic SAR Flip 9
Accumulation/Distribution Line 87
Trendline Break 11
MA Rejection 74
Coppock Curve 14

Risk Gates

0 blocking 8 caution

No active guards. 8 caution flags (visual only).

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Piotroski F-Score Caution

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for DBVT.